Shares of Praxis Precision Medicines have hit their highest intraday level since March 2022.
www.marketwatch.com
#Praxis #Precisions #tremordrug #trial #succeeds #failed #stock #skyrocketing
Praxis Precision’s tremor-drug trial succeeds where others have failed. The stock is skyrocketing.
